Guided Therapeutics (GTHP) Accounts Payables (2010 - 2026)
Guided Therapeutics (GTHP) posted Accounts Payables of $2.4 million for Q4 2025, up 1.43% sequentially from $2.4 million in Q3 2025, and up 15.38% YoY from $2.1 million in Q4 2024.
Guided Therapeutics (GTHP) Accounts Payables (2010 - 2026) Analysis & Trends
Guided Therapeutics has reported Accounts Payables for 16 years, with the latest figure at $2.4 million in Q4 2025.
- Quarterly Accounts Payables rose 15.38% year-over-year to $2.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.4 million (up 15.38% YoY) and the FY2025 annual result came in at $2.4 million, up 15.38% from the prior year.
- Accounts Payables advanced to $2.4 million in Q4 2025 per GTHP's latest filing, from $2.4 million in the prior quarter.
- Over five years, Accounts Payables peaked at $2.5 million in Q1 2022 and troughed at $1.9 million in Q1 2024.
- A 5-year average of $2.2 million and a median of $2.2 million in 2022 frame the typical range for Accounts Payables.
- The sharpest annual moves came in 2021 and 2025: Accounts Payables fell 14.91% in 2021, then advanced 15.38% in 2025.
- Over 5 years, Accounts Payables stood at $2.4 million in 2021, then retreated by 7.45% to $2.2 million in 2022, then fell by 8.92% to $2.0 million in 2023, then gained by 5.17% to $2.1 million in 2024, then rose by 15.38% to $2.4 million in 2025.
- According to Business Quant data, Accounts Payables over the past three periods registered $2.4 million, $2.4 million, and $2.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 4.79 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 1.66 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 2.64 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 1.23 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 210.50 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 3.23 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 2.42 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 344.10 Mn |
| 10 | Guided Therapeutics | 26.06 Mn | 26.05 Mn | - | 2.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.35 Mn |
| Dec 31, 2025 | 2.42 Mn |
| Sep 30, 2025 | 2.38 Mn |
| Jun 30, 2025 | 2.26 Mn |
| Mar 31, 2025 | 2.15 Mn |
| Dec 31, 2024 | 2.09 Mn |
| Sep 30, 2024 | 2.10 Mn |
| Jun 30, 2024 | 2.14 Mn |
| Mar 31, 2024 | 1.92 Mn |
| Dec 31, 2023 | 1.99 Mn |
| Sep 30, 2023 | 2.15 Mn |
| Jun 30, 2023 | 2.13 Mn |
| Mar 31, 2023 | 2.19 Mn |
| Dec 31, 2022 | 2.19 Mn |
| Sep 30, 2022 | 2.22 Mn |
| Jun 30, 2022 | 2.40 Mn |
| Mar 31, 2022 | 2.48 Mn |
| Dec 31, 2021 | 2.36 Mn |
| Sep 30, 2021 | 2.22 Mn |
| Jun 30, 2021 | 2.38 Mn |